ns6180 (Alomone Labs)
Structured Review
Ns6180, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ns6180/NS-6180/10__1128_slash_jvi__01744___18-209-13-15
Average 90 stars, based on 1 article reviews
Images
Related Articles
Infection:Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: Clotrimazole and senicapoc were obtained from MedChem Express, TRAM-34 was obtained from Sigma, and Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: The split nanoluciferase-based quantitative fusion assay is based on NanoLuc Binary Technology (NanoBiT) from Promega and the plasmids were optimized and engineered by adding GFP or RFP reporters. Activity Assay:Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: Clotrimazole and senicapoc were obtained from MedChem Express, TRAM-34 was obtained from Sigma, and Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: The split nanoluciferase-based quantitative fusion assay is based on NanoLuc Binary Technology (NanoBiT) from Promega and the plasmids were optimized and engineered by adding GFP or RFP reporters. Solvent:Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: Clotrimazole and senicapoc were obtained from MedChem Express, TRAM-34 was obtained from Sigma, and Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: The split nanoluciferase-based quantitative fusion assay is based on NanoLuc Binary Technology (NanoBiT) from Promega and the plasmids were optimized and engineered by adding GFP or RFP reporters. Control:Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: Clotrimazole and senicapoc were obtained from MedChem Express, TRAM-34 was obtained from Sigma, and Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: The split nanoluciferase-based quantitative fusion assay is based on NanoLuc Binary Technology (NanoBiT) from Promega and the plasmids were optimized and engineered by adding GFP or RFP reporters. Fluorescence:Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: Clotrimazole and senicapoc were obtained from MedChem Express, TRAM-34 was obtained from Sigma, and Article Title: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion Article Snippet: The split nanoluciferase-based quantitative fusion assay is based on NanoLuc Binary Technology (NanoBiT) from Promega and the plasmids were optimized and engineered by adding GFP or RFP reporters. |

